感染性肺炎在全球范围内具有较高的发病率和死亡率，目前临床上主要依赖抗生素、抗病毒药物和支持治疗。黄芪多糖通过直接抗病原体、免疫调节、抗炎、抗氧化、抗凋亡、疫苗佐剂、抗生素协同、修复呼吸道黏膜屏障、保护肺组织治疗感染性肺炎。总结了黄芪多糖治疗感染性肺炎的研究进展，以期为黄芪多糖的深入研发和临床应用提供依据。

Infectious pneumonia has a high incidence rate and mortality rate worldwide, and current clinical treatment primarily relies on antibiotics, antiviral drugs, and supportive therapy. Astragalus polysaccharides treat infectious pneumonia by direct pathogen resistance, immunomodulation, anti-inflammatory effects, antioxidant effects, anti-apoptosis, vaccine adjuvant effects, antibiotic synergy, repairing respiratory mucosal barriers, and protecting lung tissue. This article summarizes the research progress on astragalus polysaccharides in treating infectious pneumonia, aiming to provide a basis for further development and clinical application of astragalus polysaccharides.

R286.4